Cargando…

Tigecycline-Amikacin Combination Effectively Suppresses the Selection of Resistance in Clinical Isolates of KPC-Producing Klebsiella pneumoniae

By far, only tigecycline, colistin, and some aminoglycosides still show favorable in vitro activities against carbapenem-resistant Enterobacteriaceae. However, rapid emergence of resistance often occurs during long-term treatment in clinic, challenging these last resort antimicrobials. In this study...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ni, Wentao, Wei, Chuanqi, Zhou, Chufei, Zhao, Jin, Liang, Beibei, Cui, Junchang, Wang, Rui, Liu, Youning
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2016
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4990548/ https://www.ncbi.nlm.nih.gov/pubmed/27594855 http://dx.doi.org/10.3389/fmicb.2016.01304

Ejemplares similares

In vitro Pharmacokinetics/Pharmacodynamics Evaluation of Fosfomycin Combined with Amikacin or Colistin against KPC2-Producing Klebsiella pneumoniae
por: Yu, Wei, et al.
Publicado: (2017)

Tigecycline Susceptibility and the Role of Efflux Pumps in Tigecycline Resistance in KPC-Producing Klebsiella pneumoniae
por: He, Fang, et al.
Publicado: (2015)

Evaluation of ceftazidime/avibactam alone and in combination with amikacin, colistin and tigecycline against Klebsiella pneumoniae carbapenemase-producing K. pneumoniae by in vitro time-kill experiment
por: Wang, Fangzhou, et al.
Publicado: (2021)

In Vitro Activity of Carbapenems Alone and in Combination With Amikacin Against KPC-Producing Klebsiella Pneumoniae
por: Le, Jennifer, et al.
Publicado: (2011)

Tigecycline Treatment for Carbapenem-Resistant Enterobacteriaceae Infections: A Systematic Review and Meta-Analysis
por: Ni, Wentao, et al.
Publicado: (2016)

The Rapid Emergence of Tigecycline Resistance in bla(KPC–2) Harboring Klebsiella pneumoniae, as Mediated in Vivo by Mutation in tetA During Tigecycline Treatment
por: Du, Xiaoxing, et al.
Publicado: (2018)

In vitro Optimization of Ceftazidime/Avibactam for KPC-Producing Klebsiella pneumoniae
por: Huang, Yanqin, et al.
Publicado: (2021)

The effect of Lactobacillus with prebiotics on KPC-2-producing Klebsiella pneumoniae
por: Tang, Hung-Jen, et al.
Publicado: (2022)

Heteroresistance to Amikacin in Carbapenem-Resistant Klebsiella pneumoniae Strains
por: Zhang, Feiyang, et al.
Publicado: (2021)

Characterization of Tigecycline Resistance Among Tigecycline Non-susceptible Klebsiella pneumoniae Isolates From Humans, Food-Producing Animals, and in vitro Selection Assay
por: Moghimi, Mohaddeseh, et al.
Publicado: (2021)

Frequency and Genetic Determinants of Tigecycline Resistance in Clinically Isolated Stenotrophomonas maltophilia in Beijing, China
por: Zhao, Jin, et al.
Publicado: (2018)

Emergence of a Hypervirulent Tigecycline-Resistant Klebsiella pneumoniae Strain Co-producing bla(NDM–1) and bla(KPC–2) With an Uncommon Sequence Type ST464 in Southwestern China
por: Hao, Jingchen, et al.
Publicado: (2022)

KPC-2-producing Klebsiella pneumoniae in a hospital in the Midwest region of Brazil
por: Biberg, Camila Arguelo, et al.
Publicado: (2015)

A Full MALDI-Based Approach to Detect Plasmid-Encoded KPC-Producing Klebsiella pneumoniae
por: Cordovana, Miriam, et al.
Publicado: (2018)

Emergence of KPC-producing Klebsiella pneumoniae in Italy
por: Fontana, Carla, et al.
Publicado: (2010)

Proteomics Study of the Synergistic Killing of Tigecycline in Combination With Aminoglycosides Against Carbapenem-Resistant Klebsiella pneumoniae
por: Ma, Xinqian, et al.
Publicado: (2022)

Effect of Proton Pump Inhibitors on In Vitro Activity of Tigecycline against Several Common Clinical Pathogens
por: Ni, Wentao, et al.
Publicado: (2014)

Antimicrobial activity evaluation and comparison of methods of susceptibility for Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacter spp. isolates
por: Rechenchoski, Daniele Zendrini, et al.
Publicado: (2017)

A Novel KPC Variant KPC-55 in Klebsiella pneumoniae ST307 of Reinforced Meropenem-Hydrolyzing Activity
por: Yoon, Eun-Jeong, et al.
Publicado: (2020)

Management of infections due to KPC-producing Klebsiella pneumoniae
por: Deresinski, Stanley C, et al.
Publicado: (2009)

KPC-producing Klebsiella pneumoniae, finally targeting Turkey
por: Labarca, J, et al.
Publicado: (2014)

Evaluation of Trimethoprim/Sulfamethoxazole (SXT), Minocycline, Tigecycline, Moxifloxacin, and Ceftazidime Alone and in Combinations for SXT-Susceptible and SXT-Resistant Stenotrophomonas maltophilia by In Vitro Time-Kill Experiments
por: Wei, Chuanqi, et al.
Publicado: (2016)

Comparative Proteomics Demonstrates Altered Metabolism Pathways in Cotrimoxazole- Resistant and Amikacin-Resistant Klebsiella pneumoniae Isolates
por: Shen, Chunmei, et al.
Publicado: (2021)

Multiple Klebsiella pneumoniae KPC Clones Contribute to an Extended Hospital Outbreak
por: Ferrari, Carolina, et al.
Publicado: (2019)

Evaluation of Modified Hodge Test as a Non-molecular Assay for Accurate Detection of KPC-producing Klebsiella pneumoniae
por: GHASEMNEJAD, ATOSSA, et al.
Publicado: (2018)

Factors Associated With Short-Term Eradication of Rectal Colonization by KPC-2 Producing Klebsiella pneumoniae in an Outbreak Setting
por: Pellicé, Martina, et al.
Publicado: (2021)

Acquisition of Tigecycline Resistance by Carbapenem-Resistant Klebsiella pneumoniae Confers Collateral Hypersensitivity to Aminoglycosides
por: Chen, Hua-le, et al.
Publicado: (2021)

Intravenous plus intraventricular tigecycline-amikacin therapy for the treatment of carbapenem-resistant Klebsiella pneumoniae ventriculitis: A case report
por: Li, Jiyao, et al.
Publicado: (2022)

A Novel Tigecycline Adjuvant ML-7 Reverses the Susceptibility of Tigecycline-Resistant Klebsiella pneumoniae
por: Sun, Lilan, et al.
Publicado: (2022)

Genomic characterization of tigecycline-resistant Escherichia coli and Klebsiella pneumoniae isolates from hospital sewage
por: Li, Ying, et al.
Publicado: (2023)

Clonal Dissemination of KPC-2, VIM-1, OXA-48-Producing Klebsiella pneumoniae ST147 in Katowice, Poland
por: OCHOŃSKA, DOROTA, et al.
Publicado: (2021)

Polymyxins and Doripenem Combination Against KPC-Producing Klebsiella pneumoniae
por: Lee, Grace C., et al.
Publicado: (2013)

First detection of KPC-3-producing Klebsiella pneumoniae in Albania
por: Kostyanev, T., et al.
Publicado: (2015)

Genomic Analysis of KPC-2-Producing Klebsiella pneumoniae ST11 Isolates at the Respiratory Department of a Tertiary Care Hospital in Beijing, China
por: Guo, Ling, et al.
Publicado: (2022)

Emergence of Colistin Resistance in Carbapenem-Resistant Hypervirulent Klebsiella pneumoniae Under the Pressure of Tigecycline
por: Zhang, Yawei, et al.
Publicado: (2021)

Emergence of Klebsiella pneumoniae clinical isolates producing KPC-2 carbapenemase in Cuba
por: Quiñones, D, et al.
Publicado: (2014)

Prophylactic Use of Macrolide Antibiotics for the Prevention of Chronic Obstructive Pulmonary Disease Exacerbation: A Meta-Analysis
por: Ni, Wentao, et al.
Publicado: (2015)

Efficacy of polymyxins in the treatment of carbapenem-resistant Enterobacteriaceae infections: a systematic review and meta-analysis
por: Ni, Wentao, et al.
Publicado: (2015)

Co-conjugation of Virulence Plasmid and KPC Plasmid in a Clinical Klebsiella pneumoniae Strain
por: Yang, Xuemei, et al.
Publicado: (2021)

Reduced Ceftazidime-Avibactam Susceptibility in KPC-Producing Klebsiella pneumoniae From Patients Without Ceftazidime-Avibactam Use History – A Multicenter Study in China
por: Cui, Xiaoyan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_i8i5bgeot3b8b4p7gcia7mepg7